1.
Elgasim MAEA, Suleiman Y, Ahmed ELmubark EME, Abdalmahmoud AAA, Babkeir SAM, Omer R, Yasin R, Abaker KEA, Babker ROA, Alryah A, Alzain T. Benefits of Docetaxel for Metastatic Castration-Resistant Prostate Cancer Sudanese Patients and the Effective Number of Cycle and Dose (2013–2017). IRJO [Internet]. 2Jul.2019 [cited 9Apr.2020];2(2):1-. Available from: http://journalirjo.com/index.php/IRJO/article/view/30100